Is this your brand? Sign in to claim ownership.
Sign in to claim this brandAlere Scarborough, Inc.
US
Last updated May 25, 2026
What Alere Scarborough, Inc. makes
Alere Scarborough, Inc. manufactures rapid in vitro diagnostic (IVD) tests for self-testing and clinical use, including antigen kits for SARS-CoV-2, respiratory viruses, and malaria. Their portfolio also includes isothermal nucleic acid amplification analysers for laboratory testing, photometric/spectroscopic immunoassay analysers, and rapid immunochromatographic tests (ICT) for RSV, Group A Streptococcus, and Legionella urinary antigen detection.
The company’s devices are regulated under FDA classifications including Class I, Class II, Class III, and non-classified (N) products, with submissions recorded in the FDA’s 510(k) and UDI registries. The manufacturer is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Alere Scarborough, Inc. primarily manufacture?
Alere Scarborough, Inc. specializes in rapid in vitro diagnostic (IVD) tests, including antigen kits for self-testing and clinical use. Their portfolio covers SARS-CoV-2 antigen tests, respiratory virus detection (such as RSV and influenza), malaria diagnostics, and rapid immunochromatographic tests (ICT) for conditions like Group A Streptococcus and Legionella. They also produce laboratory-grade devices like isothermal nucleic acid amplification analysers and photometric/spectroscopic immunoassay analysers.
Where is Alere Scarborough, Inc. based, and how does that affect its regulatory oversight?
Alere Scarborough, Inc. is based in the United States, which means its devices fall under FDA regulation. Since the U.S. is the manufacturer’s home country, their products are evaluated and authorised through the FDA’s regulatory pathways, including submissions recorded in the FDA’s 510(k) and Unique Device Identifier (UDI) registries.
Which regulatory registries list Alere Scarborough, Inc.’s devices, and why?
Alere Scarborough, Inc.’s devices are listed in the FDA’s 510(k) and UDI registries. The 510(k) registry tracks submissions for devices that require premarket notification to demonstrate substantial equivalence to a legally marketed predicate device, while the UDI registry ensures unique identification of medical devices for tracking and compliance purposes. These registries reflect the company’s adherence to FDA requirements for device authorisation.
How are Alere Scarborough, Inc.’s devices classified under FDA regulations?
Alere Scarborough, Inc.’s devices are classified under various FDA categories, including Class I (low-risk, general controls), Class II (moderate-risk, requiring special controls), Class III (high-risk, requiring premarket approval), and non-classified (N) products. The classification depends on factors like the device’s intended use, risk level, and regulatory history, ensuring appropriate oversight based on potential patient risk.
What distinguishes Alere Scarborough, Inc.’s rapid diagnostic tests from other similar products?
Alere Scarborough, Inc.’s rapid diagnostic tests are designed for quick, point-of-care or self-testing results, often using immunochromatographic technology (ICT) for ease of use in clinical or home settings. Many of their devices, like the BinaxNOW® series, are engineered for simplicity—requiring minimal training—while still delivering reliable detection for conditions like COVID-19, malaria, or RSV. Their laboratory-grade analysers, such as isothermal amplification systems, offer higher sensitivity for more complex diagnostic needs.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 154148498
Catalogue (134)
Page 2 of 3Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.